olmesartan has been researched along with Hepatitis C, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enjoji, M; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Nakamuta, M; Nakashima, M | 1 |
1 trial(s) available for olmesartan and Hepatitis C, Chronic
| Article | Year |
|---|---|
Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Benzimidazoles; Benzoates; Fatty Liver; Female; Hepatitis C, Chronic; Homeostasis; Humans; Hypertension; Imidazoles; Incidence; Insulin Resistance; Japan; Male; Middle Aged; Pilot Projects; Telmisartan; Tetrazoles | 2008 |